PEG: Will It Come Back to You? Polyethelyne Glycol Immunogenicity, COVID Vaccines, and the Case for New PEG Derivatives and Alternatives

por Kong, Yi Wen, Dreaden, Erik C
Publicado 2022

Periodic-shRNA molecules are capable of gene silencing, cytotoxicity and innate immune activation in cancer cells

por Shopsowitz, Kevin E., Wu, Connie, Liu, Gina, Dreaden, Erik C., Hammond, Paula T.
Publicado 2016

A Convergent Synthetic Platform for Single-Nanoparticle Combination Cancer Therapy: Ratiometric Loading and Controlled Release of Cisplatin, Doxorubicin, and Camptothecin

por Liao, Longyan, Liu, Jenny, Dreaden, Erik C., Morton, Stephen W., Shopsowitz, Kevin E., Hammond, Paula T., Johnson, Jeremiah A.
Publicado 2014

Bimodal Tumor-Targeting from Microenvironment Responsive Hyaluronan Layer-by-Layer (LbL) Nanoparticles

por Dreaden, Erik C., Morton, Stephen W., Shopsowitz, Kevin E., Choi, Jae-Hyeok, Deng, Zhou J., Cho, Nam-Joon, Hammond, Paula T.
Publicado 2014

A Multi‐RNAi Microsponge Platform for Simultaneous Controlled Delivery of Multiple Small Interfering RNAs

por Roh, Young Hoon, Deng, Jason Z., Dreaden, Erik C., Park, Jae Hyon, Yun, Dong Soo, Shopsowitz, Kevin E., Hammond, Paula T.
Publicado 2015

Rapid Assembly and Screening of Multivalent Immune Cell-Redirecting Therapies for Leukemia

por Do, Priscilla, Perdue, Lacey A, Chyong, Andrew, Hunter, Rae, Dougan, Jodi, Henry, Curtis J, Porter, Christopher C, Dreaden, Erik C
Publicado 2020

Multicolor Light-Induced Immune Activation via Polymer Photocaged Cytokines

por Birnbaum, Lacey A., Sullivan, Emily C., Do, Priscilla, Uricoli, Biaggio, Raikar, Sunil S., Porter, Christopher C., Henry, Curtis J., Dreaden, Erik C.
Publicado 2023

Layer-by-Layer Assembled Antisense DNA Microsponge Particles for Efficient Delivery of Cancer Therapeutics

por Roh, Young Hoon, Lee, Jong Bum, Shopsowitz, Kevin E., Dreaden, Erik C., Morton, Stephen W., Poon, Zhiyong, Hong, Jinkee, Yamin, Inbar, Bonner, Daniel K., Hammond, Paula T.
Publicado 2014

B-cell acute lymphoblastic leukemia promotes an immune suppressive microenvironment that can be overcome by IL-12

por Hunter, Rae, Imbach, Kathleen J., Zhou, Chengjing, Dougan, Jodi, Hamilton, Jamie A. G., Chen, Kevin Z., Do, Priscilla, Townsel, Ashley, Gibson, Greg, Dreaden, Erik C., Waller, Edmund K., Haynes, Karmella A., Henry, Curtis J., Porter, Christopher C.
Publicado 2022

Therapeutic Targeting of MERTK and BCL-2 in T-Cell and Early T-Precursor Acute Lymphoblastic Leukemia

por Summers, Ryan J., Jain, Juhi, Vasileiadi, Eleana, Smith, Brittany, Chimenti, Madison L., Yeung, Tsz Y., Kelvin, James, Wang, Xiaodong, Frye, Stephen V., Earp, H. Shelton, Tyner, Jeffrey W., Dreaden, Erik C., DeRyckere, Deborah, Graham, Douglas K.
Publicado 2022

RNA‐Peptide nanoplexes drug DNA damage pathways in high‐grade serous ovarian tumors

por Dreaden, Erik C., Kong, Yi Wen, Quadir, Mohiuddin A., Correa, Santiago, Suárez‐López, Lucia, Barberio, Antonio E., Hwang, Mun Kyung, Shi, Aria C., Oberlton, Benjamin, Gallagher, Paige N., Shopsowitz, Kevin E., Elias, Kevin M., Yaffe, Michael B., Hammond, Paula T.
Publicado 2018

Enhancing chemotherapy response through augmented synthetic lethality by co-targeting nucleotide excision repair and cell-cycle checkpoints

por Kong, Yi Wen, Dreaden, Erik C., Morandell, Sandra, Zhou, Wen, Dhara, Sanjeev S., Sriram, Ganapathy, Lam, Fred C., Patterson, Jesse C., Quadir, Mohiuddin, Dinh, Anh, Shopsowitz, Kevin E., Varmeh, Shohreh, Yilmaz, Ömer H., Lippard, Stephen J., Reinhardt, H. Christian, Hemann, Michael T., Hammond, Paula T., Yaffe, Michael B.
Publicado 2020